-Search query
-Search result
Showing 1 - 50 of 65 items for (author: ritter & c)
EMDB-18639:
Locally refined SARS-CoV-2 BA-2.86 Spike receptor binding domain (RBD) complexed with angiotensin converting enzyme 2 (ACE2)
Method: single particle / : Ren J, Stuart DI, Duyvesteyn HME
EMDB-18649:
Local refinement of SARS-CoV-2 BA.2.86 Spike and XBB-7 Fab
Method: single particle / : Ren J, Duyvesteyn HME, Stuart DI
EMDB-19002:
XBB-4 Fab in complex with SARS-CoV-2 BA.2.12.1 Spike Glycoprotein
Method: single particle / : Duyvesteyn HME, Ren J, Stuart DI
PDB-8qsq:
Locally refined SARS-CoV-2 BA-2.86 Spike receptor binding domain (RBD) complexed with angiotensin converting enzyme 2 (ACE2)
Method: single particle / : Ren J, Stuart DI, Duyvesteyn HME
PDB-8qtd:
Local refinement of SARS-CoV-2 BA.2.86 Spike and XBB-7 Fab
Method: single particle / : Ren J, Duyvesteyn HME, Stuart DI
PDB-8r8k:
XBB-4 Fab in complex with SARS-CoV-2 BA.2.12.1 Spike Glycoprotein
Method: single particle / : Duyvesteyn HME, Ren J, Stuart DI
EMDB-15489:
180 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
EMDB-15490:
200 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
EMDB-15491:
215 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
EMDB-15492:
235 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
EMDB-15493:
250 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
EMDB-15494:
270 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
EMDB-15495:
280 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
EMDB-15496:
305 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
EMDB-15497:
290 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
EMDB-15498:
320 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
EMDB-15499:
365 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
PDB-8akq:
180 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
PDB-8akr:
200 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
PDB-8aks:
215 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
PDB-8akt:
235 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
PDB-8aku:
250 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
PDB-8akv:
270 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
PDB-8akw:
280 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
PDB-8akx:
305 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
PDB-8aky:
290 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
PDB-8akz:
320 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
PDB-8al0:
365 A SynPspA rod after incubation with ATP
Method: helical / : Junglas B, Hudina E, Schoennenbeck P, Ritter I, Santiago-Schuebel B, Huesgen P, Sachse C
EMDB-17719:
human mitoribosomal large subunit assembly intermediate 1 with GTPBP10-GTPBP7
Method: single particle / : Kummer E, Nguyen TG, Ritter C
EMDB-17720:
human mitoribosomal large subunit assembly intermediate 2 with GTPBP7
Method: single particle / : Kummer E, Nguyen TG
EMDB-17721:
human mitoribosomal large subunit assembly intermediate 3 with GTPBP5
Method: single particle / : Kummer E, Nguyen TG
PDB-8pk0:
human mitoribosomal large subunit assembly intermediate 1 with GTPBP10-GTPBP7
Method: single particle / : Kummer E, Nguyen TG, Ritter C
PDB-8qsj:
Human mitoribosomal large subunit assembly intermediate 2 with GTPBP7
Method: single particle / : Ritter C, Nguyen TG, Kummer E
EMDB-15971:
SARS-CoV-2 Delta-RBD complexed with Fabs BA.2-36, BA.2-23, EY6A and COVOX-45
Method: single particle / : Duyvesteyn HME, Ren J, Stuart DI
PDB-8bcz:
SARS-CoV-2 Delta-RBD complexed with Fabs BA.2-36, BA.2-23, EY6A and COVOX-45
Method: single particle / : Duyvesteyn HME, Ren J, Stuart DI
EMDB-14885:
OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
Method: single particle / : Duyvesteyn HME, Ren J, Stuart DI
EMDB-14886:
OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement)
Method: single particle / : Duyvesteyn HME, Ren J, Stuart DI
EMDB-14887:
OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
Method: single particle / : Duyvesteyn HME, Ren J, Stuart DI
EMDB-14910:
OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE
Method: single particle / : Duyvesteyn HME, Ren J, Stuart DI
PDB-7zr7:
OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
Method: single particle / : Duyvesteyn HME, Ren J, Stuart DI
PDB-7zr8:
OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement)
Method: single particle / : Duyvesteyn HME, Ren J, Stuart DI
PDB-7zr9:
OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
Method: single particle / : Duyvesteyn HME, Ren J, Stuart DI
PDB-7zrc:
OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE
Method: single particle / : Duyvesteyn HME, Ren J, Stuart DI
EMDB-13857:
Beta049 fab in complex with SARS-CoV2 beta-Spike glycoprotein, The Beta mAb response underscores the antigenic distance to other SARS-CoV-2 variants
Method: single particle / : Duyvesteyn HME, Ren J, Stuart DI
EMDB-13868:
Beta-50 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
Method: single particle / : Duyvesteyn HME, Ren J, Stuart DI
EMDB-13869:
COVOX-222 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
Method: single particle / : Duyvesteyn HME, Ren J, Stuart DI
EMDB-13870:
Beta-43 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
Method: single particle / : Duyvesteyn HME, Ren J, Stuart DI
EMDB-13871:
Beta-26 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
Method: single particle / : Duyvesteyn HME, Ren J, Stuart DI
EMDB-13872:
Beta-32 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
Method: single particle / : Duyvesteyn HME, Ren J, Stuart DI
EMDB-13873:
Beta-53 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
Method: single particle / : Duyvesteyn HME, Ren J, Stuart DI
Pages: